Day: March 5, 2025

Prelude Therapeutics to Participate in Barclays 27th Annual Global Healthcare Conference

Written by Customer Service on March 5, 2025. Posted in Public Companies.

WILMINGTON, Del., March 05, 2025 (GLOBE NEWSWIRE) — Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will participate in the Barclays 27th Annual Global Healthcare Conference, taking place in Miami, FL on March 11, 2025. On Tuesday, March 11, 2025, at 12:30 p.m. ET, Kris Vaddi, Ph.D., Chief Executive Officer of Prelude, Jane Huang, M.D., President and Chief Medical Officer, and Bryant Lim, Chief Financial Officer will participate in a fireside chat. A live webcast of the fireside chat can be accessed on the Company’s website under Events and Presentations. The recording will be archived and available on the Company’s website for 90 days. About Prelude Therapeutics Prelude Therapeutics is a leading precision oncology company developing innovative...

Kamada Reports Record Top and Bottom Line 2024 Financial Results and Affirms 2025 Guidance Representing Double-Digit Profitable Growth

Written by Customer Service on March 5, 2025. Posted in Earnings Releases And Operating Results.

Record Year with Total 2024 Revenues of $161.0 Million, Representing a 13% Increase over Fiscal Year 2023 and Adjusted EBITDA of $34.1 Million, Up 42% Year-over-Year, and a 21% Margin of Revenues Cash Provided by Operating Activities of $47.6 Million During 2024 Resulted in a Year-End Strong Cash Balance of $78.4 Million; Solid Financial Position to Accelerate Inorganic Growth Net Income for the Year was $14.5 Million, or $0.25 per Diluted Share, Up 75% Year-over-Year Strong Performance Positions Company for Double Digit Profitable Growth in Fiscal Year 2025; Reiterates 2025 Full-Year Revenue Guidance of $178 Million to $182 Million and Adjusted EBITDA of $38 Million to $42 Million Declares Special Cash Dividend of $0.20 Per Share (Totaling Approximately $11.5 Million) Conference Call and Live Webcast Today at 8:00am ETREHOVOT, Israel,...

Ocugen Provides Business Update with Fourth Quarter and Full Year 2024 Financial Results

Written by Customer Service on March 5, 2025. Posted in Earnings Releases And Operating Results.

Conference Call and Webcast Today at 8:30 a.m. ETReached an alignment with FDA on Phase 2/3 pivotal confirmatory clinical trial for OCU410ST for Stargardt disease potentially expediting clinical development by two to three years Completed dosing in OCU410 Phase 2 ArMaDa clinical trial (N=51) for geographic atrophy (GA). Data and Safety Monitoring Board (DSMB) recently reviewed interim safety data from Phase 2. All subjects from multiple dose levels in Phase 2 to date demonstrated a very favorable safety and tolerability profile. Positive 2-year long-term data across multiple mutations of retinitis pigmentosa (RP) from the Phase 1/2 clinical trial of OCU400 demonstrated a durable and statistically significant (p=0.005) improvement in visual function (LLVA) in all evaluable treated subjects at two years when compared to untreated eyes OCU400...

Natural Gas Services Group, Inc. Announces Reporting Date for Q4 and Full-Year 2024 Earnings Conference Call

Written by Customer Service on March 5, 2025. Posted in Earnings Releases And Operating Results.

Midland, Texas, March 05, 2025 (GLOBE NEWSWIRE) — Natural Gas Services Group, Inc. (NYSE:NGS), a leading provider of natural gas compression equipment, technology and services to the energy industry, will host a conference call to review its fourth-quarter and fiscal 2024 financial results on March 18, 2025 at 8:30 a.m. (EST), 7:30 a.m. (CST). The Company’s Q4 2024 financial and operating results for the full year ending in December 31, 2024 will be disseminated via press release and made available on the Company’s website (www.ngsgi.com) after market close on March 17, 2025. To join the conference call, kindly access the Investor Relations section of our website at www.ngsgi.com or dial in at (800) 550-9745 and enter conference ID: 167298 at least five minutes prior to the scheduled start time. Please note that using the provided...

THOR Industries Announces Second Quarter Fiscal 2025 Results

Written by Customer Service on March 5, 2025. Posted in Earnings Releases And Operating Results.

POISED FOR A MARKET RETURNFiscal 2025 Second Quarter Highlights ($ in thousands, except for per share data) Three Months Ended January 31, Change Six Months Ended January 31, Change 2025 2024 2025 2024 Net Sales $ 2,018,107 $ 2,207,369 (8.6 )% $ 4,160,891 $ 4,708,128 (11.6 )%Gross Profit $ 245,197 $ 270,847 (9.5 )% $ 526,639 $ 628,779 (16.2 )%Gross Profit Margin % 12.1 % 12.3 % (20) bps 12.7 13.4 (70) bps Net Income (Loss) Attributable to THOR $ (551 ) $ 7,217 (107.6 )% $ (2,383 ) $ 60,782 (103.9 )%Diluted Earnings (Loss) Per Share $ (0.01 ) $ 0.13 (107.7 )% $ (0.04 ) $ 1.13 (103.5 )%Cash Flows from Operations $ 30,842 $ (103,868 ) 129.7 % $ 61,582 $ (44,200 ) 239.3 % EBITDA(1) $ 76,344 $ 103,242 $ 158,077 $ 263,299 Adjusted...

John Krenicki Jr. to Retire from Devon Energy Board of Directors

Written by Customer Service on March 5, 2025. Posted in Public Companies.

OKLAHOMA CITY, March 05, 2025 (GLOBE NEWSWIRE) — Devon Energy Corp. (NYSE: DVN) announced today that John Krenicki Jr. is retiring from the company’s board of directors at the end of his current term and will not stand for re-election at the company’s annual meeting of stockholders, which is scheduled for June 4, 2025. Mr. Krenicki plans to focus on his full-time responsibilities at CD&R, a private equity firm where he currently serves as Vice Chairman. “John Krenicki has served with distinction on Devon’s board since 2018, leaving a mark through his dedication. We are grateful for his years of service, during which he offered strategic guidance and wise counsel, including with the transformative merger of Devon and WPX Energy in 2021. We wish John the best in the continued growth of his private equity ventures,”...

Flutter Entertainment plc Announces Launch of Second Tranche of Share Repurchase Program

Written by Customer Service on March 5, 2025. Posted in Public Companies.

NEW YORK, March 05, 2025 (GLOBE NEWSWIRE) — Flutter Entertainment plc (“Flutter”) (NYSE:FLUT; LSE:FLTR), the world’s leading online sports betting and iGaming operator, announces that it has entered into non-discretionary arrangements with Goldman Sachs & Co. LLC to repurchase ordinary shares on Flutter’s behalf for an aggregate maximum consideration of up to $300 million on the New York Stock Exchange (the “Buyback”). The Buyback will commence on April 1, 2025 on the New York Stock Exchange, and will end no later than June 30, 2025. The purpose of the Buyback is to reduce the share capital of Flutter. This Buyback is the second tranche of the multi-year share repurchase program of up to $5bn announced on September 25, 2024. In 2025, we expect to return approximately $1bn to shareholders via the program. Goldman Sachs...

YieldMax™ ETFs Announces Distributions on FIAT (101.61%), ULTY (82.09%), CONY (79.47%), YMAX (85.55%), YMAG (48.55%) and Others

Written by Customer Service on March 5, 2025. Posted in Dividend Reports And Estimates.

CHICAGO, MILWAUKEE and NEW YORK, March 05, 2025 (GLOBE NEWSWIRE) — YieldMax™ today announced distributions for the YieldMax™ Weekly Payers and Group C ETFs listed in the table below.ETF Ticker1 ETF Name Distribution Frequency Distribution per Share Distribution Rate2,4 30-DaySEC Yield3 ROC5 Ex-Date & Record Date Payment DateQDTY YieldMax™ Nasdaq 100 0DTE Covered Call ETF Weekly $0.1580 – – 33.90% 3/6/25 3/7/25SDTY YieldMax™ S&P 500 0DTE Covered Call ETF Weekly $0.1709 – – 100.00% 3/6/25 3/7/25GPTY YieldMax™ AI & Tech Portfolio Option Income ETF Weekly $0.3094 37.80% 0.00% 0.00% 3/6/25 3/7/25LFGY YieldMax™ Crypto Industry& Tech Portfolio Option Income ETF Weekly $0.4637 61.48% 0.00% 0.00% 3/6/25 3/7/25YMAX YieldMax™ UniverseFund...

Barnwell Industries, Inc. Disqualifies Ned Sherwood’s Board Nominees Included in Defective and Insufficient Nomination Notice for 2025 Annual Meeting

Written by Customer Service on March 5, 2025. Posted in Public Companies.

Sets March 14, 2025, as Record Date for Shareholders to Act by Written Consent in Connection with Sherwood’s Latest Self-Serving Campaign to Take Control of Barnwell Sherwood’s Consent Solicitation is Yet Another Attempt to Steal the Company from Shareholders Without Paying a Premium for Control HONOLULU, March 05, 2025 (GLOBE NEWSWIRE) — Barnwell Industries, Inc. (NYSE American: BRN) (“Barnwell” or the “Company”) today announced that the Executive Committee of the Barnwell Board of Directors has disqualified the controlling slate of director nominees submitted by one of its shareholders, Ned Sherwood, in connection with 2025 Annual Meeting of Shareholders. As previously disclosed on February 25, 2025, the Executive Committee informed Sherwood that it rejected his nomination notice because it was defective and insufficient as it...

Radware and CHT Security Join Forces to Deliver AI-Powered Application Security in Taiwan

Written by Customer Service on March 5, 2025. Posted in Public Companies.

Provide one-stop shop to help organizations defend against a rise in hacker attacks MAHWAH, N.J., March 05, 2025 (GLOBE NEWSWIRE) — Radware® (NASDAQ: RDWR), a global leader in application security and delivery solutions for multi-cloud environments, today announced it signed a managed security service provider (MSSP) agreement with CHT Security (stock code: 7765). The new agreement represents an expansion of an existing relationship. CHT Security, one of Taiwan’s leading MSSPs, is a subsidiary and security arm of Chunghwa Telecom Co., Ltd., the largest telco in the country. CHT Security is leveraging Radware’s AI-powered Cloud Application Protection Services to further enhance its product portfolio and offer customers across Taiwan state-of-the-art application security. CHT Security also uses Radware’s on-prem DefensePro® DDoS...

Day: March 5, 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals